The question of timing, meaning when during the day or relative to activity to inject, depends on the clinical goal
Important Note on the Evidence Base To our knowledge, no peer-reviewed clinical or preclinical study has tested the specific GHK-Cu + BPC-157 + TB-500 three-component combination at the amounts or ratios sold in this product
Your unstimulated baseline is therefore not zero, and it is not close to zero
Samples were treated by heat precipitation (99C, 10 min) followed by centrifugation (12,000 g, 10 min)
The drugs would still not be FDA-approved, and the FDA would still not vouch for their safety or effectiveness. Koehl Robinson, founder and CEO of CeliaRX, a telehealth company that sells injectable and topical peptides compounded by a 503A pharmacy partner (not the ones on the FDAs potential unbanned list), says that if the peptides are reclassified, it would likely open up new possibilities for her customers, as well as lead to more clarity and less confusion